Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001305775 | SCV001495122 | likely benign | not provided | 2024-11-27 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000778649 | SCV005088801 | likely pathogenic | Deficiency of beta-ureidopropionase | 2020-03-11 | criteria provided, single submitter | clinical testing | This variant was previously reported in a compound heterozygous state in two unrelated individuals with beta-ureidopropionase deficiency [PMID: 22525402, 24526388]. Expression of the variant in E. coli yielded almost no detectable enzyme activity and structural analysis of the protein indicated that the variant abolishes the hydrogen bond to another amino acid, which may affect the shape of the entrance to the binding site [PMID: 22525402]. |